Literature DB >> 6655019

Determination of coumarin anticoagulant rodenticide residues in animal tissue by high-performance liquid chromatography. I. Fluorescence detection using post-column techniques.

K Hunter.   

Abstract

A multi-residue method was developed for the determination of the rodenticides warfarin, coumatetralyl, bromadiolone, difenacoum and brodifacoum in animal tissues by high-performance liquid chromatography with fluorescence detection. Extracts were cleaned-up by gel permeation chromatography on Bio-Beads SX-3 and residues determined by normal and reversed-phase high-performance liquid chromatography using post-column pH-switching, with chloroform -sec.-butylamine and borate buffer (pH 10.4) respectively, to maximise the native fluorimetric responses. Confirmation of identification was possible by re-chromatographing extracts in the absence of the post-column reagent. Chloroform-acetone (1:1) was significantly better than chloroform for the extraction of residues of these rodenticides from liver tissues. Recoveries from spiked liver tissue were generally greater than 90% at levels of 0.05-1 mg kg-1. Detection limits in animal tissues of 0.002 mg kg-1 for coumatetratyl, difenacoum and brodifacoum, 0.01 mg kg-1 for bromadiolone and 0.02 mg kg-1 for warfarin and could be routinely achieved.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6655019     DOI: 10.1016/s0021-9673(01)96372-1

Source DB:  PubMed          Journal:  J Chromatogr


  2 in total

1.  Detection of anticoagulant rodenticides (4-hydroxycoumarins) by thin-layer chromatography and reversed-phase high-performance liquid chromatography with fluorescence detection.

Authors:  I Rengel; A Friedrich
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

2.  Separation and Quantification of Superwarfarin Rodenticide Diastereomers-Bromadiolone, Difenacoum, Flocoumafen, Brodifacoum, and Difethialone-in Human Plasma.

Authors:  Daniel G Nosal; Douglas L Feinstein; Luying Chen; Richard B van Breemen
Journal:  J AOAC Int       Date:  2020-06-01       Impact factor: 2.028

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.